Blood Screening Market is anticipated to reach USD 3.9 billion by 2024. It is anticipated to grow at a healthy rate in the years to come. Blood is a living tissue made up of liquid, with several proteins and cells suspended in it. It contains red blood cells, circulating fluid, platelets, and white blood cells. It offers nutrition and oxygen to the body cells through arteries, capillaries, and veins. It also helps in removal of carbon dioxide and metabolic waste from the body. Blood screening implies medical procedure wherein blood is inspected for a specific condition or disease. It helps to monitor health issues & diseases and a chronic ailments such as cancer and infections.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/blood-screening-market/request-sample
Market Synopsis of Blood Screening Market:
The facts that propel the growth
of the Market include surge in adoption of nucleic acid amplification test
(NAT), increase in prevalence of infectious diseases, rise in awareness
regarding healthcare, and increase in the number of blood donations.
Furthermore, surge in healthcare expenditure, increase in healthcare
initiatives by government, and technical developments in blood screening technologies
have resulted in the market growth.
On the other hand, factors such
as dearth of skilled manpower, high operating costs, and strict regulatory
approvals may hinder the market development. The introduction of pathogen
reduction technology and microbiology screening & multiplexing are
anticipated to offer profitable opportunities for the blood screening market.
and grow at a significant CAGR of 10.2% in the upcoming period as the scope,
product types, and its applications are increasing across the globe.
Blood Screening Market may be
analyzed based on technology, product outlook, end users, and geography. The
Market may be explored by technology as ELISA, Chemiluminescence Immunoassay
(CLIA), and Enzyme Immunoassay (EIA), Nucleic Acid Amplification Test (NAT),
Western Blotting, and Next-Generation Sequencing (NGS). The NAT may be further
split into real-time PCR and transcription-mediated amplification (TMA). The
“NAT” dominated the blood screening market in 2016 and is anticipated to
maintain its dominance by 2024 due to growing number of blood donations,
increasing occurrence of transferrable diseases, and growing disposable income
with respect to reimbursement for NAT-tested blood.
Furthermore, the increasing
consciousness about advanced and innovative applications of NAT in disease
screening and the growing demand for safe donated blood by patients suffering
from thalassemia, hemophilia, and sickle-cell anemia boost the development of
this technology sector. Blood Screening Market may be explored by product
outlook as Reagent& kit, and Instrument.
The market may be analyzed based
on end user into Blood Banks, and Hospitals. The “blood banks” segment
dominated the market in 2016 and anticipated to maintain its dominance by 2024
due to factors such as growing demand for donated blood, rising number of
rising awareness regarding the safety of blood, organ transplantation
surgeries, growing number of donations worldwide, and development in government
funding to charitable trusts.
North America accounted for the
major share of the global Blood Screening Industry in 2016 and will continue to
lead in the forecast period due to factors such as growing participation of
several government associations in screening & transfusion activities and
blood donations, and rising adoption of nucleic acid tests (NAT).
View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/blood-screening-market
Table of Contents:-
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Blood Screening: Market
Variables, Trends & Scope
Chapter 4 Blood Screening: Product
Estimates & Trend Analysis
Chapter 5 Blood Screening:
Application Estimates & Trend Analysis
Chapter 6 Blood Screening:
End-use Estimates & Trend Analysis
Chapter 7 Blood Screening:
Industrial End-use Estimates & Trend Analysis
Chapter 8 Blood Screening:
Regional Estimates & Trend Analysis
Chapter 9 Competitive Landscape
Chapter 10 Blood Screening:
Manufacturers Company Profiles
Get in touch
At Million Insights, we work with
the aim to reach the highest levels of customer satisfaction. Our representatives
strive to understand diverse client requirements and cater to the same with the
most innovative and functional solutions.
No comments:
Post a Comment